Sarah Bianchi, Evercore ISI public policy chief strategist, joins 'Squawk Box' to discuss the short-term government funding ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $307.2, a high ...

Evercore ISI raised the firm’s price target on BridgeBio (BBIO) to $50 from $45 and keeps an Outperform rating on the shares ...

Tax-loss selling candidates such as Nike, could surprise investors with big gains in 2025, say Evercore strategists.

Retrenchment in industry has led to concerns about the spread of ‘pharmacy deserts’ with limited access to medicines ...

Cabaletta Bio Inc (CABA) stock saw a decline, ending the day at $2.36 which represents a decrease of $-0.02 or -0.84% from the prior close of $2.38. The stock opened at $2.4 and touched a low of $2.25 ...

Evercore ISI analyst Gavin Clark-Gartner maintained a Buy rating on Rocket Pharmaceuticals (RCKT – Research Report) on December 20 and set a ...

Keefe Bruyette upgraded Evercore (EVR) to Outperform from Market Perform with a price target of $339, up from $269. The firm says that despite ...

Fintel reports that on December 20, 2024, Keefe, Bruyette & Woods upgraded their outlook for Evercore (NYSE:EVR) from Market ...

Investing.com -- Evercore ISI initiated positive tactical calls on Target Corporation (NYSE:TGT) and Best Buy Co Inc (NYSE:BBY) on improved holiday shopping trends and favourable spending ...

Across the recent three months, 5 analysts have shared their insights on Evercore (NYSE:EVR), expressing a variety of opinions spanning from bullish to bearish. The table below offers a condensed ...

ChargePoint (NYSE: CHPT) has disappointed a lot of investors since its public debut. The electric vehicle (EV) charging ...